B

BioTheryX, Inc.

44 employees

Biotheryx is a clinical-stage biopharmaceutical company that focuses on the development of protein degrader therapies

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Biotech
Therapeutics
Inflammatory Disorders
Targeted Protein Degredation
Medical
Small Molecules
Cancer

Date founded

2008

Funding rounds raised

Total raised

$92M

from 10 investors over 10 rounds

B

BioTheryX, Inc. raised $6M on April 5, 2023

Investors: Incyte

B

BioTheryX, Inc. raised $92M on May 20, 2021

Investors: Irving Investors, Lumira Ventures, Surveyor Capital, Wedbush Securities, Farallon Capital Management, Point72 Asset Management, S.R. One Ltd and Tekla Capital Management

B

BioTheryX, Inc. raised $35M on July 28, 2020

Investors: BDT & MSD Partners

FAQ